Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity

被引：0
|
作者：
Nicola Sverzellati
Mario Silva
Valeria Seletti
Carlotta Galeone
Stefano Palmucci
Sara Piciucchi
Carlo Vancheri
Venerino Poletti
Sara Tomassetti
Ronald Karwoski
Brian J. Bartholmai
机构：
[1] University of Parma,Scienze Radiologiche, Department of Medicine and Surgery
[2] University of Milan,Department of Clinical Sciences and Community
[3] University Hospital “Policlinico-Vittorio Emanuele”,Department of Medical and Surgical Sciences and Advanced Technologies
[4] Ospedale GB Morgagni,Radiodiagnostic and Radiotherapy Unit
[5] University of Catania,Department of Radiology, Azienda USL Romagna
[6] Aarhus University Hospital,Department of Clinical and Experimental Medicine
[7] Ospedale G.B. Morgagni,Department of Respiratory Diseases and Allergy
[8] Mayo Clinic,Department of Diseases of the Thorax
[9] Mayo Clinic,Biomedical Imaging Resource
来源：
European Radiology | 2020年 / 30卷
关键词：
Idiopathic pulmonary fibrosis; Multidetector computed tomography; Usual interstitial pneumonia; Outcome; Machine learning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2669 / 2679
页数：10
相关论文
共 50 条
  • [1] Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity
    Sverzellati, Nicola
    Silva, Mario
    Seletti, Valeria
    Galeone, Carlotta
    Palmucci, Stefano
    Piciucchi, Sara
    Vancheri, Carlo
    Poletti, Venerino
    Tomassetti, Sara
    Karwoski, Ronald
    Bartholmai, Brian J.
    EUROPEAN RADIOLOGY, 2020, 30 (05) : 2669 - 2679
  • [2] Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
    Zappala, C. J.
    Latsi, P. I.
    Nicholson, A. G.
    Colby, T. V.
    Cramer, D.
    Renzoni, E. A.
    Hansell, D. M.
    du Bois, R. M.
    Wells, A. U.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 35 (04) : 830 - 835
  • [3] Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
    Bermudo, Guadalupe
    Suarez-Cuartin, Guillermo
    Rivera-Ortega, Pilar
    Rodriguez-Portal, Jose Antonio
    Sauleda, Jaume
    Nunez, Belen
    Castillo, Diego
    Aburto, Myriam
    Portillo, Karina
    Balcells, Eva
    Badenes-Bonet, Diana
    Valenzuela, Claudia
    Fernandez-Fabrellas, Estrella
    Gonzalez-Budino, Teresa
    Cano, Esteban
    Acosta, Orlando
    Leiro-Fernandez, Virginia
    Romero, Ana
    Planas-Cerezales, Lurdes
    Villar, Ana
    Moreno, Amalia
    Laporta, Rosalia
    Vicens-Zygmunt, Vanesa
    Shull, Jessica
    Franquet, Tomas
    Luburich, Patricio
    Molina-Molina, Maria
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (02): : 135 - 141
  • [4] Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
    Eva Santermans
    Paul Ford
    Michael Kreuter
    Nadia Verbruggen
    Paul Meyvisch
    Wim A. Wuyts
    Kevin K. Brown
    David J. Lederer
    Adam J. Byrne
    Philip L. Molyneaux
    Arunon Sivananthan
    Catharina C. Moor
    Toby M. Maher
    Marlies Wijsenbeek
    Advances in Therapy, 2019, 36 : 3059 - 3070
  • [5] The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis
    Assayag, Deborah
    Vittinghoff, Eric
    Ryerson, Christopher J.
    Cocconcelli, Elisabetta
    Tonelli, Roberto
    Hu, Xiaowen
    Elicker, Brett M.
    Golden, Jeffrey A.
    Jones, Kirk D.
    King, Talmadge E., Jr.
    Koth, Laura L.
    Lee, Joyce S.
    Ley, Brett
    Shum, Anthony K.
    Wolters, Paul J.
    Ryu, Jay H.
    Collard, Harold R.
    RESPIRATORY MEDICINE, 2015, 109 (08) : 1058 - 1062
  • [6] Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design
    Santermans, Eva
    Ford, Paul
    Kreuter, Michael
    Verbruggen, Nadia
    Meyvisch, Paul
    Wuyts, Wim A.
    Brown, Kevin K.
    Lederer, David J.
    Byrne, Adam J.
    Molyneaux, Philip L.
    Sivananthan, Arunon
    Moor, Catharina C.
    Maher, Toby M.
    Wijsenbeek, Marlies
    ADVANCES IN THERAPY, 2019, 36 (11) : 3059 - 3070
  • [7] Prognostic value of forced expiratory volume in 1 second/forced vital capacity in idiopathic pulmonary fibrosis
    Nishiyama, Osamu
    Yamazaki, Ryo
    Sano, Akiko
    Yamagata, Toshiyuki
    Sano, Hiroyuki
    Iwanaga, Takashi
    Higashimoto, Yuji
    Kume, Hiroaki
    Tohda, Yuji
    CHRONIC RESPIRATORY DISEASE, 2016, 13 (01) : 40 - 47
  • [8] Forced vital capacity (FVC) decline in idiopathic pulmonary fibrosis (IPF) - modelling the myth
    Wijsenbeek, Marlies
    Santermans, Eva
    Ford, Paul
    Kreuter, Michael
    Verbruggen, Nadia
    Meyvisch, Paul
    Wuyts, Wim
    Brown, Kevin
    Lederer, David
    Maher, Toby
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [9] Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis
    Tajiri, Morihiro
    Okamoto, Masaki
    Fujimoto, Kiminori
    Johkoh, Takeshi
    Ono, Junya
    Tominaga, Masaki
    Azuma, Koichi
    Kawayama, Tomotaka
    Ohta, Shoichiro
    Izuhara, Kenji
    Hoshino, Tomoaki
    RESPIRATORY INVESTIGATION, 2015, 53 (02) : 73 - 81
  • [10] Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone
    Higo, Hisao
    Miyahara, Nobuaki
    Taniguchi, Akihiko
    Senoo, Satoru
    Itano, Junko
    Watanabe, Hiromi
    Oda, Naohiro
    Kayatani, Hiroe
    Ichikawa, Hirohisa
    Shibayama, Takuo
    Kajimoto, Kazuhiro
    Tanimoto, Yasushi
    Kanehiro, Arihiko
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    RESPIRATORY INVESTIGATION, 2020, 58 (03) : 185 - 189
12345